GEHC's PEG ratio is not computable because the earnings growth data is negative or zero. GE HealthCare Technologies last had a PEG ratio of 4.18 in December 2025.
A two years lookback shows an average PEG ratio of 1.46 for GE HealthCare Technologies. GEHC reached its maximum PEG ratio of 4.18 during the Dec 2025 quarter over the past two years. The Jun 2025 quarter had the bottom reading at 0.37, indicating the most optimal growth-adjusted valuation.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 4.18 | 17.99 | 4.3% |
| 2024 | 0.41 | 17.89 | 43.3% |
| 2023 | N/A | 25.35 | -27.7% |
| 2022 | N/A | N/A | -14.7% |
| 2021 | N/A | N/A | N/A |
| 2020 | N/A | N/A | N/A |
| 2019 | N/A | N/A | N/A |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | N/A | 17.03 | -12.6% |
| Dec 2025 | 4.18 | 17.99 | 4.3% |
| Sep 2025 | 0.49 | 15.48 | 31.8% |
| Jun 2025 | 0.37 | 15.12 | 41.2% |
| Mar 2025 | 0.44 | 16.88 | 38.6% |
| Dec 2024 | 0.41 | 17.89 | 43.3% |
| Sep 2024 | 2.87 | 25.5 | 8.9% |
| Jun 2024 | N/A | 22.46 | -4.4% |
| Mar 2024 | N/A | 26.35 | -8.7% |
| Dec 2023 | N/A | 25.35 | -27.7% |
| Sep 2023 | N/A | 20.13 | N/A |
| Jun 2023 | N/A | 22.38 | N/A |
| Mar 2023 | N/A | 21.7 | N/A |
| Dec 2022 | N/A | N/A | -14.7% |
| Sep 2022 | N/A | N/A | N/A |
| Stock name | PEG ratio | Market cap |
|---|---|---|
| OBIO Orchestra BioMed Holdings Inc | N/A | $250.9M |
| OM Outset Medical Inc | N/A | $87.5M |
| GEHC GE HealthCare Technologies Inc | N/A | $29.82B |
GEHC's PEG ratio is unavailable because EPS growth data is negative or not present.
GEHC has a 3-year average PEG ratio of 1.46.
In the last two years, GEHC's peak PEG ratio of 4.18 was recorded in the Dec 2025 quarter.
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.